Average Co-Inventor Count = 6.12
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Schering Pharma Ag (6 from 192 patents)
2. Bayer Aktiengesellschaft (1 from 12,164 patents)
3. Schering Aktiengesellschaft (1 from 1,384 patents)
4. Bayer Healthcare LLC (1 from 778 patents)
5. Schring Aktiengesellschaft (1 from 1 patent)
6. Bayer Intellectual Property Gmbh (721 patents)
10 patents:
1. 11951166 - Combination of regorafenib and PD-1/PD-L1(2) inhibitors for treating cancer
2. 11517622 - Combination of regorafenib and PD-1/PD-L1(2) inhibitors for treating cancer
3. 8003787 - Sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors
4. 7977325 - 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents
5. 7741333 - Quinazoline derivatives, their preparation, their use, and medicaments comprising them
6. 7601748 - Anti-androgenic pyrrolidines with tumor-inhibiting action
7. 7598263 - Cyanoquinoline derivatives, their preparation, their use, and medicaments comprising them
8. 7361645 - Androgenic 7-substituted 11-halogen steroids
9. 7138421 - Anti-androgenic pyrrolidines with tumor-inhibiting action
10. 6861432 - Piperazine derivatives that destabilize androgen receptors